End-of-day quote
Other stock markets
|
||
- GBX | - |
10/05 | StanChart exec sells shares; new Alphawave CFO buys | AN |
07/05 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 4.81B 6.13B 511B | Sales 2025 * | 4.99B 6.36B 530B | Capitalization | 1.94B 2.48B 206B |
---|---|---|---|---|---|
Net income 2024 * | 152M 194M 16.15B | Net income 2025 * | 163M 208M 17.32B | EV / Sales 2024 * | 0.53 x |
Net Debt 2024 * | 618M 787M 65.63B | Net Debt 2025 * | 505M 644M 53.69B | EV / Sales 2025 * | 0.49 x |
P/E ratio 2024 * |
13.1
x | P/E ratio 2025 * |
11.4
x | Employees | - |
Yield 2024 * |
2.24% | Yield 2025 * |
2.59% | Free-Float | 98.05% |
Latest transcript on Serco Group plc
Managers | Title | Age | Since |
---|---|---|---|
Mark Irwin
CEO | Chief Executive Officer | 59 | 01/13/01 |
Nigel Crossley
DFI | Director of Finance/CFO | 61 | 01/14/01 |
Paul Checketts
IRC | Investor Relations Contact | - | 01/20/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Irwin
CEO | Chief Executive Officer | 59 | 01/13/01 |
Lynne Peacock
BRD | Director/Board Member | 70 | 01/17/01 |
John Rishton
CHM | Chairman | 66 | 13/16/13 |
1st Jan change | Capi. | |
---|---|---|
+12.50% | 68.79B | |
+7.35% | 17.45B | |
+20.68% | 13.58B | |
+8.66% | 13.35B | |
+12.48% | 9.8B | |
-20.94% | 6.74B | |
-4.74% | 5.95B | |
+2.67% | 5.23B | |
-3.21% | 4.85B |